TDOC لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

03
السعر $5.52
القيمة السوقية (الربع الأخير) $1.00B
P/E (سنوي حالي) -5.6
ربح السهم (سنوي حالي) $-0.99
الإيرادات (سنوي حالي) $2.49B
ROE (سنوي حالي) -13.0%
نطاق 52 أسبوعًا $4–$10

TDOC مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

04
نطاق
أشرطة

تتكيف دقة الشريط مع الفترة المحددة - مرر مؤشر الفأرة فوق الرسم البياني لرؤية الافتتاح/الأعلى/الأدنى/الإغلاق للشريط.

حول Teladoc Health, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا

05 · wikidata

Teladoc Health, Inc. is an American telemedicine and virtual healthcare company founded in 2002. Headquartered in New York City, its services include telehealth, employer-sponsored health plans, 24/7 care, mental health, diabetes and hypertension management, primary care, prescriptions, medical opinions, AI and analytics, telehealth devices and licensable platform services.

The company uses telephone and videoconferencing software and mobile apps to provide on-demand remote medical care. Teladoc Health is active in over 175 countries, and is traded on the New York Stock Exchange. It is the first and largest telemedicine company in the United States, and has acquired numerous other companies including BetterHelp in 2015, Best Doctors in 2017, and Catapult Health in 2025.

History

2002–2015

Teladoc was founded in 2002 in Dallas, Texas by G. Byron Brooks and Michael Gorton. It is the oldest and largest telemedicine company in the United States. Teladoc's initial business model allowed patients to remotely consult with state-licensed doctors at any time. Companies paid a monthly fee for their employees to access the service, while patients paid a flat fee for each consultation, originally about $35 to $40. With Gorton as both chairman and CEO, Teladoc launched nationally in 2005 at the Consumer Directed Health Care Conference in Chicago, Illinois. Teladoc had around 1 million members by the end of 2007, with large employers such as AT&T providing the service to employees as a health benefit. Jason Gorevic was named Teladoc's chief executive in 2009. In 2011, Aetna began offering Teladoc for its fully insured members in Florida and Texas, later offering Teladoc in all 50 states.

Teladoc acquired Consult A Doctor for $16.6 million cash in 2013, allowing smaller companies to access Teladoc's services. The Affordable Care Act led to a large number of insurance companies signing with Teladoc, resulting in a growth surge around 2014. By that time, insurance companies such as Blue Shield of California and Oscar had signed with Teladoc, as well as other companies such as Home Depot, T-Mobile, CalPERS, and Rent-A-Center. Teladoc acquired AmeriDoc for $17.2 million in May 2014. The acquisitions of Consult A Doctor and AmeriDoc, both Teladoc's main competitors, resulted in Teladoc becoming the largest telemedicine provider in the United States. After initial fundraising rounds in 2009, 2011, and 2013, Teladoc raised $50 million in 2014, bringing total funding to $100 million. Teladoc's sales doubled in both 2013 and 2014.

2015–2016

Teladoc Health became a public company on July 1, 2015 as the only telemedicine company on the New York Stock Exchange. Teladoc's initial public offering listed at $19 per share, giving the company a market capitalization of $758 million and an enterprise value of $620 million. The initial response to the IPO was positive, as shares surged 50% on the opening day. Three months after the IPO, health insurer Highmark, which represented 1.5% of Teladoc's 2015 revenue, ceased to renew a contract. Teladoc shares fell significantly as a result, before rising to earlier levels. That October, it was the first telehealth company to reach one million visits.

In 2015, Teladoc acquired the behavioral health services provider Compile Inc., operating as BetterHelp for $3.5 million, and competitor Stat Health Services (StatDoc) for $30 million. The following year Teladoc began aggressively expanding, acquiring other companies and launching health segments for dermatology, behavioral health, and sexual health. That year the company won a patent infringement lawsuit filed against competitor American Well.

In July 2016, Teladoc acquired HealthiestYou for $125 million ($45 million in cash and $80 million in stock). Teladoc had 15 million members by November 2016 and a market share of 75% in the United States. The largest national network of virtual care providers in the nation, its full-service suite was operational in 48 states, excluding Arkansas and Texas. In December 2016, the American Hospital Association exclusively endorsed Teladoc's telehealth technology platform. Teladoc logged 952,000 patient visits that year.

2017–2020

In its largest acquisition at the time, in 2017 Teladoc spent $440 million purchasing Best Doctors, a consultation firm and provider of medical second opinions and medical award listings. In 2019, ProPublica criticized companies such as Best Doctors for selling physician awards as pay-to-play. Teladoc had 7,500 clients in 2017, of which 220 were Fortune 1000 companies. Sales that year were $233 million, 89% higher than the year prior. Teladoc Health brands by 2018 included Teladoc, Advance Medical, Best Doctors, BetterHelp and HealthiestYou.

On August 10, 2018, Teladoc, Inc. changed its name to Teladoc Health, Inc. while continuing to trade on the NYSE. Teladoc Health began partnering with CVS in August 2018 on remote consults at MinuteClinics. Teladoc Health acquired Advance Medical, a telemedicine company employing doctors in Latin America, Europe, and Asia, for $352 million in 2018. In December 2018, Teladoc Health's chief financial officer and chief operating officer Mark Hirschhorn resigned after a report that he engaged in a sexual relationship and insider trading with an employee. According to Yahoo Finance, stock value fell roughly 20% in the days following, while an investor class action lawsuit alleged that Teladoc Health had violated securities laws by failing to disclose Hirschhorn's behavior. Teladoc Health denied making false statements or any legal violations.

Active in 130 countries by 2019; that year, Teladoc acquired the French health company MédecinDirect and launched in Canada with the Teladoc Telemedicine Service. Joining from American Express, Mala Murthy was appointed CFO in June 2019.

In March 2020, Teladoc was providing "near real-time" surveillance data on the spread of coronavirus to the CDC. In July 2020, Teladoc acquired InTouch Health. In October 2020, Teladoc acquired the chronic care company Livongo Health for $13.9 billion in a deal described by the press as the third-largest for a U.S. company that year. The combined companies had an estimated enterprise value of $37 billion. Teladoc then brought in Florida Blue as the first insurer to use Livongo's digital diabetes program. Teladoc sued Amwell in October 2020 for alleged copyright infringement on nine patents, settling the case in July 2022.

2021–2024

In early 2021, paid membership in the U.S. was 52 million. In January 2021, Teladoc began offering a diabetes management service through Dexcom. Later that year, Teladoc Health launched myStrength Complete, a "unified mental health care platform for its B2B customers." In June 2021, Teladoc sued the company Avail for allegedly infringing on three patents related to telemedicine consoles.

On July 14, 2021, Teladoc announced it was collaborating with Microsoft to combine its delivery platform for hospitals and health systems with Microsoft Teams. Teladoc introduced its primary care service Primary360 on a national scale in October 2021. The program gave members access to both a primary physician and care team, with a system in place for followup reminders about appointments and personal maintenance. In February 2022, Teladoc Health launched Chronic Care Complete, a program to help patients manage multiple chronic conditions.

Teladoc had a valuation of roughly $11.3 billion by February 2022, and warned investors there might be a goodwill write-down that year related to the Livongo acquisition. Teladoc announced that Amazon could newly access Teladoc through Alexa and related devices, in February 2022, sparking debate among antitrust experts about the potential impact on the health industry. Amazon Care was shut down later that year.

In April 2022, Northwell Health began using the Teladoc platform with its clinicians, starting with 20 hospitals in the system. After Teladoc's stock value fluctuated significantly during the coronavirus pandemic, the company, in June 2022, was sued by investors alleging it had misrepresented its financial prospects, particularly in regard to its BetterHelp mental health subsidiary and chronic care business. Characterizing the lawsuit, which was later dismissed, as "frivolous," in July 2022, Teladoc reported revenue growth above analysts' projections, with significant growth in BetterHelp. In August 2022, Teladoc became the telehealth portal for Mayo Clinic Health System patients in Onalaska, Wisconsin.

In 2023, the company relocated its headquarters to new York City. Charles "Chuck" Divita, III, was appointed CEO in June 2024, leading the company's further expansion. In July, the firm launched Wellbound employee assistance program (EAP), incorporating BetterHelp into its U.S. employer-sponsored health plans.

2025–present

In January 2025, the company added its virtual cardiometabolic programs to Amazon Health Services health benefits connector. That year, Teladoc Health made a series of acquisitions, including Catapult Health in February, mental healthcare company UpLift in April, and Australia's Telecare virtual care firm in August.

In March 2025, the FTC fined BetterHelp $7.8 million for sharing consumer data with third-party social media sites, banning the company from health data disclosures for advertising purposes. Subsequent to the dismissed June 2022 lawsuit, a new class-action was filed by investors in the U.S. District Court for the Southern District of New York on May 17, 2025.

The company reported over 100 million U.S. members in July 2025, and launched new AI capabilities for healthcare workplaces to monitor and mitigate violence that October. In November, Teladoc Health joined with Lumeris, Deloitte, Nuna and Unite Us as Collaborative for Healthy Rural America, pledging to build a shared, integrated care platform, following individual states' plan approvals from the new Rural Health Transformation (RHT) Program of the U.S. Department of Health and Human Services.

Services and business model

Headquartered in New York City, the company operates two main components: Teladoc Health Integrated Care, its virtual care business for health plans, employers and health networks, and BetterHelp direct-to-consumer virtual mental health care. As a technology company, Teladoc Health is involved with artificial intelligence, analytics, telehealth devices, and "licensable platform services." The company uses telephone and videoconferencing software to provide on-demand remote medical care, with patients able to log on to the service at any time and be connected with a board-certified, state-licensed physician. Its app combines all of its services and programs.

Contracting largely with insurers and large employers, hospitals and health systems, Teladoc Health generates revenue through an annual, or monthly, fee charged per subscriber, as well as a fee for individual consults. Some companies waive or subsidize the consult fee for their employees.

By July 2020, the company stated it served "60 of the top 100 hospitals," with telemedical robots being used at hospitals such as Providence Regional Medical Center in Everett, Washington and Sheba Medical Center in Israel, minimizing the potential spread of coronavirus. Numerous studies analyzing Teladoc's impact on the industry have been conducted.

Disaster aid

Teladoc Health provides free telehealth visits to communities affected by federally declared natural disasters and public emergencies in the United States, including to victims of incidents such as the 2018 Camp Fire in Paradise, California, Hurricane Ida in 2021, and the 2025 Southern California wildfires. In March 2023, it began providing free care to residents in Mississippi affected by recent tornadoes and, in 2024, to communities in several states that were impacted by Hurricanes Milton and Helene.

Lobbying and legislation

Teladoc Health has been involved in lobbying for legislation in several states. In 2015 the Texas Medical Board ruled that state physicians had to physically meet patients before remotely treating ailments or prescribing medication. The bill undermined Teladoc Health's business model in Texas, where it had around two million subscribers. Teladoc Health sued in federal court over the rule in Teladoc v. Texas Medical Board, arguing the bill violated antitrust laws by inflating prices and limiting the supply of health care providers in the state. The bill, meant to go active on June 3, 2015, was stalled while the lawsuit went through a federal appeals court, allowing Teladoc Health to continue operating in Texas in the interim. Teladoc voluntarily dropped the lawsuit in 2017 after Texas passed a new bill allowing for remote treatment without a prior in-person interaction, which Teladoc Health had lobbied heavily for.

In January 2019, Teladoc Health opposed a telemedicine bill proposed by the North Dakota Board of Medicine, which required telemedicine providers to perform initial video examinations or have initial exams done by another physician. Proponents argued the bill protected patients, while Teladoc Health and critics argued it decreased access to healthcare in rural areas. The year prior, Teladoc Health had completed 1,500 virtual visits in the state. In May 2019, the company created a virtual care patient safety organization (PSO) dubbed the Institute for Patient Safety and Quality of Virtual Care.

In December 2021, Teladoc along with the American Medical Association, American Hospital Association, AARP, Amazon, Walmart, and CVS formed Telehealth Access for America, a coalition pushing for the extension of telehealth policies implemented by U.S. Congress in response to the COVID-19 pandemic. Subsequently, U.S. Senators Bill Cassidy and Tammy Baldwin introduced the Health Data Use and Privacy Commission Act in February 2022, which proposes creating a commission to study modernizing health data and privacy laws. The proposed legislation was supported by Teladoc and organizations such as the American College of Cardiology, IBM, and the United Spinal Association.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

قطاعHealth Care صناعةHealth Care موظفون4648 بلدUS

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

06
الإيرادات$2.53B
2016-12-31 → 2025-12-31
ربح السهم$-1.14
2019-12-31 → 2025-12-31
التدفق النقدي الحر$285M
2017-12-31 → 2025-12-31
هامش صافي-7.1%
2017-12-31 → 2025-12-31
التقييم والنسب 07–12

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس اتجاه 5 سنوات TDOC متوسط 5 سنوات متوسط الأقران الحكم
P/E (سنوي حالي) -5.6متوسط 5 سنوات ≈-11.5 ≈-11.5 · ·
السعر/المبيعات (سنوي حالي) 0.4متوسط 5 سنوات ≈2.3 ≈2.3 2.5 مقوّم بأقل من قيمته
السعر / القيمة الدفترية (الربع الأخير) 0.8متوسط 5 سنوات ≈1.2 ≈1.2 2.9 مقوّم بأقل من قيمته
السعر / التدفق النقدي الحر (سنوي حالي) 4.0متوسط 5 سنوات ≈24.5 ≈24.5 · ·
السعر / التدفق النقدي (سنوي حالي) 3.8متوسط 5 سنوات ≈23.2 ≈23.2 12.7 مقوّم بأقل من قيمته
السعر / القيمة الدفترية الملموسة (الربع الأخير) 7.5 · · ·

يتم حساب الوسيط النظير على أساس موحد لكل مقياس وقد لا يتطابق دائمًا مع الأساس السنوي الحالي/الربع الأخير المعروض لهذا السهم.

القيمة · ≈ متوسط 5 سنوات · متوسط الصناعة · حكم مقارنة بالمتوسط

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

14
متوسط المفاجأة 0.53%
التقرير القادم أكتوبر 27, 2026
الفترةتقريرEPS ActualEPS المتوقعالمفاجأة
30 يونيو، 2026 يوليو 27, 2026 $-0.21 $-0.25 17.6%
31 مارس، 2026 $-0.36 $-0.32 -12.6%
31 ديسمبر، 2025 $-0.14 $-0.19 26.9%
30 سبتمبر، 2025 $-0.28 $-0.27 -3.2%
30 يونيو، 2025 $-0.19 $-0.27 28.7%
31 مارس، 2025 $-0.53 $-0.34 -54.2%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

15
قائمة الدخل 18
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M$44M
Cost of Revenue ···$744M$650M$391M$184M$129M$62M$32M$21M$10M
Gross Profit ·······$289M$172M$91M$56M$34M
R&D Expense $278M$307M$349M$334M$312M$165M$65M$54M$34M$22M$14M$8M
SG&A Expense $432M$435M$465M$450M$438M$507M$164M$117M$80M$49M$43M$18M
Operating Expenses $2.79B$3.59B$2.85B$16.06B$2.30B$1.60B$634M$489M$309M···
Operating Income $-263M$-1.02B$-249M$-13.65B$-266M$-506M$-80M$-71M$-75M$-63M$-56M$-15M
Interest Expense ·$24M$22M$22M$81M·······
Interest Income $37M$57M$47M$13M$776.0K·······
Other Non-op $10M$-6M$4M$-859.0K$5M$-545.0K$342.0K·····
Pretax Income $-236M$-994M$-220M$-13.66B$-385M$-576M$-109M$-97M$-107M$-74M$-58M$-17M
Income Tax $-35M$8M$760.0K$-4M$44M$-91M$-11M$118.0K$-225.0K$510.0K$36.0K$388.0K
Net Income $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M$-17M
EPS (Basic) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
EPS (Diluted) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
Shares (Basic) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
Shares (Diluted) 176,221,530170,564,088164,578,219161,457,123156,939,34990,509,22971,844,535·····
EBITDA $-263M$-1.02B$-249M$-13.40B$-61M$-437M$-80M$-35M$-56M·$-51M·
الميزانية العمومية 28
المقياس اتجاه 202520242023202220212020201920182017201620152014
Cash & Equivalents $781M$1.30B$1.12B$918M$893M$733M$514M$424M$43M$50M$55M$46M
Short-term Investments ·······$55M$79M$16M$82M·
Receivables $193M$214M$217M$211M$169M$169M$57M$44M$27M$14M$12M$7M
Inventory $38M$38M$30M$56M$73M$56M$0·····
Prepaid Expense $107M$113M$118M$130M$87M$47M$14M$11M$7M$3M$2M$966.0K
Other Current Assets $2M$3M$7M$12M$6M·······
Current Assets $1.12B$1.66B$1.49B$1.32B$1.23B$1.06B$588M$533M$156M$83M$152M$54M
PP&E (Net) $27M$29M$32M$30M$27M$29M$10M$10M$9M$7M$6M$1M
PP&E (Gross) $112M$101M$92M$77M$61M$51M$26M$22M$17M$12M$8M$2M
Accum. Depreciation $85M$71M$60M$48M$34M$22M$16M$12M$8M$4M$2M$1M
Goodwill $283M$283M$1.07B$1.07B$14.50B$14.58B$746M$737M$499M$188M$56M$28M
Intangibles $1.30B$1.43B$1.68B$1.84B$1.91B$2.02B$225M$247M$160M$25M$15M$8M
Other Non-current Assets $106M$81M$80M$49M$21M$18M$7M$1M$858.0K$415.0K$293.0K$296.0K
Total Assets $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Accounts Payable $48M$33M$44M$48M$47M$46M$9M$8M$4M$2M$2M$2M
Current Liabilities $405M$942M$421M$400M$331M$333M$90M$62M$40M$21M$18M$10M
Capital Leases $34M$32M$43M$38M$42M$43M$25M$0····
Deferred Tax $29M$50M$49M$51M$76M$102M$22M$32M$13M$2M$1M$482.0K
Other Non-current Liabilities $643.0K$720.0K$1M$2M$1M$2M$9M$6M$5M$8M$7M$3M
Total Liabilities $1.47B$2.03B$2.07B·········
Long-term Debt ·········$44M$26M$26M
Total Debt ····$0$43M····$26M·
Common Stock $178.0K$173.0K$167.0K$163.0K$160.0K$150.0K$73.0K$70.0K$61.0K$46.0K$38.0K$2.0K
Retained Earnings $-16.43B$-16.23B$-15.23B$-15.01B$-1.42B$-993M$-508M$-409M$-312M$-205M$-131M$-72M
AOCI $-35M$-38M$-37M$-43M$-6M$19M$-17M$-13M$4M$-1.0K$-42.0K·
Stockholders' Equity $1.39B$1.49B$2.33B$2.31B$16.05B$15.88B$1.01B$1.01B$559M$231M$179M$-68M
Liabilities + Equity $2.86B$3.52B$4.39B$4.35B$17.73B$17.76B$1.60B$1.53B$824M$304M$230M$92M
Shares Outstanding 178,315,400173,405,016166,658,253162,840,360160,469,325150,281,09972,761,94170,516,24961,534,10146,201,56338,524,9222,037,999
التدفق النقدي 18
المقياس اتجاه 202520242023202220212020201920182017201620152014
D&A ···$256M$204M$69M$39M$36M$19M$8M$5M$2M
Stock-based Comp $80M$146M$202M$218M$303M$476M$67M$44M$31M$8M$3M$533.0K
Deferred Tax $-41M$-1M$-2M$-8M$41M$-91M$-11M$-2M$-591.0K$510.0K$36.0K$388.0K
Amort. of Intangibles $351M$363M$326M$245M$195M$65M$36M$32M$15M$6M$4M$2M
Restructuring $19M$20M$17M$7M···$1M····
Other Non-cash ···$13.38B$75M$-23M·$15M$23M·$3M·
Operating Cash Flow $294M$294M$350M$189M$194M$-54M$30M$-5M$-34M$-52M$-47M$-11M
CapEx $9M$11M$11M$16M$9M$4M$4M$4M$3M$2M$6M$1M
Investing Cash Flow $-266M$-124M$-156M$-168M$-73M$-591M$25M$-257M$-448M$26M$-108M·
Debt Issued ·······$10.0K$167M$35M$7M$20M
Net Debt Issued ······$0$10.0K$-60M·$468.0K·
Stock Issued ·····$0$0$331M$259M$250.0K$163M·
Stock Repurchased ···········$368.0K
Net Stock Activity ·····$0$0$331M$259M···
Financing Cash Flow $-552M$8M$11M$6M$41M$859M$35M$646M$475M$21M$164M·
Taxes Paid $9M$9M$7M$3M$4M$1M$1M$441.0K$137.0K···
Free Cash Flow $285M$283M$339M$173M$185M$-58M$26M$-9M$-37M·$-53M·
Levered FCF ·$259M$316M·········
الربحية 8
المقياس اتجاه 202520242023202220212020201920182017201620152014
Gross Margin ·······69.2%73.6%·72.8%·
Operating Margin -10.4%-39.7%-9.6%-567.3%-13.1%-46.3%-14.5%-17.0%-32.3%·-72.1%·
Net Margin -7.9%-39.0%-8.5%-567.5%-21.1%-44.4%-17.9%-23.2%-45.8%·-75.0%·
Pretax Margin -9.3%-38.7%-8.4%-567.7%-18.9%-52.6%-19.8%-23.2%-45.9%·-74.9%·
EBITDA Margin -10.4%-39.7%-9.6%-556.6%-3.0%-39.9%-14.5%-8.4%-24.1%·-65.8%·
ROA -6.3%-25.3%-5.0%-123.7%-2.4%-5.0%-6.3%-8.2%-18.9%·-36.1%·
ROE -14.3%-66.8%-9.5%-326.8%-2.7%-5.4%-9.8%-9.5%-27.0%·-104.5%·
ROIC -16.1%-69.0%-10.7%-591.5%-1.8%-2.7%-7.2%-7.0%-13.5%·-27.2%·
السيولة والملاءة 5
المقياس اتجاه 202520242023202220212020201920182017201620152014
Current Ratio 2.81.83.53.33.73.26.58.53.9·8.4·
Quick Ratio 2.41.63.22.83.22.76.38.43.7·8.3·
Debt / Equity ····0.00.0····0.1·
LT Debt / Equity ··········0.1·
Interest Coverage ·-42.9-11.2·········
الكفاءة 3
المقياس اتجاه 202520242023202220212020201920182017201620152014
Asset Turnover 0.80.60.60.20.10.10.40.40.4·0.5·
Inventory Turnover ···11.510.013.8······
Receivables Turnover 12.411.912.212.712.09.711.011.811.4·8.2·
لكل سهم 5
المقياس اتجاه 202520242023202220212020201920182017201620152014
Book Value / Share $7.77$8.60$13.96$14.17$99.99$105.69$13.94$14.37$9.08·$4.63·
Revenue / Share $14.36$15.07$15.81$14.91$12.95·······
Cash Flow / Share $1.67$1.72$2.13$1.17$1.24·······
Cash / Share $4.38$7.49$6.74$5.64$5.57$4.88$7.07$6.01$0.70·$1.43·
EPS (TTM) $-1.14$-5.87$-1.34$-84.60$-2.73$-5.36$-1.38·····
معدلات النمو 3
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue YoY -1.5%-1.3%8.1%18.4%85.8%·······
Revenue CAGR 3Y 1.7%8.1%33.5%·········
Revenue CAGR 5Y 18.3%···········
التقييم (آخر 12 شهرًا) 13
المقياس اتجاه 202520242023202220212020201920182017201620152014
Revenue TTM $2.53B$2.57B$2.60B$2.41B$2.03B$1.09B$553M$418M$233M$123M$77M·
Net Income TTM $-200M$-1.00B$-220M$-13.66B$-429M$-485M$-99M$-97M$-107M$-74M$-58M·
Market Cap $1.25B$1.58B$3.59B$3.85B$14.73B$30.05B$6.09B$3.50B$2.14B·$692M·
Enterprise Value ····$13.84B$29.36B····$581M·
P/E -6.1-1.5-16.1-0.3-33.6-37.3-60.7·····
P/S 0.50.61.41.67.227.511.08.49.2·8.9·
P/B 0.91.11.51.70.91.96.03.53.8·3.9·
P / Cash Flow 4.25.410.320.376.0-561.6203.9-719.2-62.3·-14.7·
P / FCF 4.45.610.622.379.4-522.3231.1-394.0-57.8·-12.9·
EV / EBITDA ····-225.4-67.2····-11.4·
EV / FCF ····74.6-510.3····-10.9·
EV / Revenue ····6.826.8····7.5·
Earnings Yield -16.3%-64.6%-6.2%-357.7%-3.0%-2.7%-1.7%·····

أحدث فترة على اليسار · القيم الفارغة معروضة كـ ·

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

16
المقياس 2025-12-312024-12-312023-12-312022-12-312021-12-31
الإيرادات $2.53B $2.57B $2.60B $2.41B $2.03B
هامش الربح التشغيلي % -10.4% -39.7% -9.6% -567.3% -13.1%
صافي الدخل $-200M $-1.00B $-220M $-13.66B $-429M
EPS المخفف $-1.14 $-5.87 $-1.34 $-84.60 $-2.73

الملاك المؤسسيون (13F) 393 مقدمي إقرار · $1.5B إجمالي · حتى تاريخ 30 سبتمبر، 2026

17

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

حائزون 393
القيمة المحتفظ بها $1.5B
مراكز جديدة 65
المراكز الخارجة 34
النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
65 (-2 مقابل الربع السابق) 34 (-38 مقابل الربع السابق) 111 (-8 مقابل الربع السابق) 94 (+9 مقابل الربع السابق) +11.8M

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
VANGUARD GROUP INC $150385949 21483707 9,91% الأسهم
BlackRock, Inc. $137572176 16223134 9,07% الأسهم
VANGUARD PORTFOLIO MANAGEMENT LLC $107573820 12685592 7,09% الأسهم
Point72 Asset Management, L.P. $69874581 8239927 4,61% الأسهم
RENAISSANCE TECHNOLOGIES LLC $68457700 8072842 4,51% الأسهم
Voss Capital, LP $68235838 8046679 4,50% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $67458671 7955032 4,45% الأسهم
DIMENSIONAL FUND ADVISORS LP $62515646 7371699 4,12% الأسهم
STATE STREET CORP $42080999 4962382 2,77% الأسهم
AMERICAN CENTURY COMPANIES INC $41505394 4894504 2,74% الأسهم
Allianz Asset Management GmbH $39572734 4666596 2,61% الأسهم
GEODE CAPITAL MANAGEMENT, LLC $39472353 4653834 2,60% الأسهم
GOLDMAN SACHS GROUP INC $32412969 3822284 2,14% الأسهم
Monaco Asset Management SAM $26864462 3167979 1,77% الأسهم
JUPITER ASSET MANAGEMENT LTD $26370375 3109714 1,74% الأسهم
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $25976377 3063252 1,71% الأسهم
Quantinno Capital Management LP $23904416 2818917 1,58% الأسهم
FEDERATED HERMES, INC. $18037027 2127008 1,19% الأسهم
UBS Group AG $17401181 2052026 1,15% الأسهم
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $17299632 2040051 1,14% الأسهم
AMERIPRISE FINANCIAL INC $16998584 2004550 1,12% الأسهم
Pale Fire Capital SE $16737502 1973762 1,10% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $16435088 1938100 1,08% عقد خيار الشراء
NORTHERN TRUST CORP $15055374 1775398 0,99% الأسهم
AQR CAPITAL MANAGEMENT LLC $14855924 1751878 0,98% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11710032 1380900 0,77% عقد خيار البيع
BRIDGEWAY CAPITAL MANAGEMENT, LLC $11348708 1338291 0,75% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $11229479 1324231 0,74% الأسهم
MORGAN STANLEY $11055129 1303670 0,73% الأسهم
VANGUARD FIDUCIARY TRUST CO $10120074 1193405 0,67% الأسهم
BNP PARIBAS FINANCIAL MARKETS $9796800 1155283 0,65% الأسهم
FRANKLIN RESOURCES INC $9710439 1145099 0,64% الأسهم
Allspring Global Investments Holdings, LLC $9024853 991742 0,59% الأسهم
Freestone Grove Partners LP $7338160 865349 0,48% الأسهم
Man Group plc $6880545 811385 0,45% الأسهم
PRINCIPAL FINANCIAL GROUP INC $6827859 805172 0,45% الأسهم
CITADEL ADVISORS LLC $6795024 801300 0,45% عقد خيار البيع
Union Square Park Capital Management, LLC $6784000 800000 0,45% الأسهم
CITADEL ADVISORS LLC $6532093 770294 0,43% الأسهم
FMR LLC $6449076 760504 0,43% الأسهم
TCW GROUP INC $6248039 736797 0,41% الأسهم
Voss Capital, LP $5936000 700000 0,39% عقد خيار الشراء
Empowered Funds, LLC $5764619 679790 0,38% الأسهم
Bank of New York Mellon Corp $5535043 652717 0,36% الأسهم
D. E. Shaw & Co., Inc. $5420493 639209 0,36% الأسهم
PEAK6 LLC $5227920 616500 0,34% عقد خيار الشراء
CITADEL ADVISORS LLC $5114288 603100 0,34% عقد خيار الشراء
Squarepoint Ops LLC $5089696 600200 0,34% عقد خيار الشراء
JANE STREET GROUP, LLC $5088848 600100 0,34% عقد خيار البيع
JPMORGAN CHASE & CO $4283818 484856 0,28% الأسهم

عرض جميع الملاك المؤسسيين البالغ عددهم 393 →

الناشطون والمالكون بنسبة 5%+ 2 حيازتان

18

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Kinnevik AB (publ), Invik S.A. ×3 إيداعات 15 إبريل، 2021 · إيداع أولي · SEC
General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 إيداعات 16 مارس، 2021 · إيداع أولي · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

المطلعون على الشركة 56 من المطلعين · مسؤولون 29 · مديرون 24

19
مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Charles Divita III CHIEF EXECUTIVE OFFICER 10 سبتمبر، 2026 M 465535 0 7 $-1035229
Laizer Kornwasser Advisor to the CEO 1 أغسطس، 2024 M 99929 0 0 $0
Jason N Gorevic CHIEF EXECUTIVE OFFICER 19 مارس، 2024 A 653073 0 0 $0
Michael F Grasher Chief Financial Officer 1 سبتمبر، 2026 A · 0 0 $0
Mala Murthy CHIEF FINANCIAL OFFICER 29 أغسطس، 2025 M 142385 0 0 $0
Mark Hirschhorn Executive VP, COO and CFO 13 ديسمبر، 2018 M 10000 0 0 $0
Carlos Nueno President, International 1 سبتمبر، 2026 M 64744 0 4 $-218769
Fernando M. Rodrigues President of BetterHelp 1 سبتمبر، 2026 M 0 0 8 $-469637
Kelly Bliss President, U.S. Group Health 1 سبتمبر، 2026 M 92832 0 7 $-343192
Peter A Mcclennen President 15 يوليو، 2019 M 0 0 0 $0
Michael Willem Waters CHIEF OPERATING OFFICER 30 أغسطس، 2024 M 78309 0 0 $0
David William Sides Chief Operating Officer 29 يوليو، 2021 M 11031 0 0 $0
Joseph Ronald Catapano Chief Accounting Officer 1 سبتمبر، 2026 M 12865 0 7 $-48940
Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY 1 سبتمبر، 2026 M 117616 0 4 $-289541
Vidya Raman-Tangella CHIEF MEDICAL OFFICER 4 سبتمبر، 2024 S 33665 0 0 $0
Andrew Turitz EVP, CORPORATE DEVELOPMENT 4 سبتمبر، 2024 S 20773 0 0 $0
James L. Cave INTERIM CAO 30 أغسطس، 2024 M 13808 0 0 $0
Nikolaos P. Nanis Chief Technology Officer 30 أغسطس، 2024 M 75410 0 0 $0
Arnnon Geshuri CHIEF PEOPLE OFFICER 30 أغسطس، 2024 M 44914 0 0 $0
Daniel Trencher CHIEF STRATEGY OFFICER 30 أغسطس، 2024 M 31465 0 0 $0
Stephany Verstraete CHIEF MARKETING OFFICER 30 أغسطس، 2024 M 48843 0 0 $0
Richard J Napolitano CHIEF ACCOUNTING OFFICER 19 مارس، 2024 A 18077 0 0 $0
Claus Torp Jensen CHIEF INNOVATION OFFICER 1 ديسمبر، 2023 M 20703 0 0 $0
Lewis Levy Chief Medical Officer 1 أكتوبر، 2020 M 8766 0 0 $0
Michelle Bucaria Chief Human Resources Officer 1 سبتمبر، 2020 M 3232 0 0 $0
Christopher Caridi Chief Accounting Officer 1 يوليو، 2020 A · 0 0 $0
Gabriel R. Cappucci Senior VP, Controller and CAO 16 إبريل، 2020 M 988 0 0 $0
Michael H. King Chief Sales Officer 25 مايو، 2017 A 61459 0 0 $0
Peter N. Nieves EVP and CRO 13 مارس، 2017 A · 0 0 $0
Mark V Anquillare مدير 3 أغسطس، 2026 A · 0 0 $0
Catherine Jacobson مدير 21 مايو، 2026 A 66853 0 0 $0
Mark Douglas Smith مدير 21 مايو، 2026 A 8355 0 0 $0
Kenneth H Paulus مدير 21 مايو، 2026 A 10000 1 0 $69400
David B Snow JR مدير 21 مايو، 2026 A 113032 0 0 $0
David L Shedlarz مدير 21 مايو، 2026 A 61266 0 0 $0
Susan R Salka مدير 30 مارس، 2026 A · 0 0 $0
Michael S Smith مدير 18 فبراير، 2026 A · 0 0 $0
Jason Eric Evans مدير 19 ديسمبر، 2025 M 9145 0 0 $0
Thomas Mckinley مدير 22 مايو، 2025 A 56544 0 0 $0
Karen L Daniel مدير 22 مايو، 2024 M 36995 0 0 $0
William H. Frist مدير 26 مايو، 2022 A 12918 0 0 $0
Christopher Bischoff مدير 17 مايو، 2022 M 7195 0 0 $0
Hemant Taneja مدير 19 إبريل، 2021 S 118760 0 0 $0
Glen Tullman مدير 1 إبريل، 2021 M 275793 0 0 $0
Helen Darling مدير 11 يونيو، 2020 M 918 0 0 $0
Arneek Multani مدير 30 مايو، 2019 A 918 0 0 $0
Brian P Mcandrews مدير 30 مايو، 2019 A 1965 0 0 $0
Tom Mawhinney مدير 25 مايو، 2018 M 46203 0 0 $0
Martin R Felsenthal مدير 8 أغسطس، 2016 A 10860 0 0 $0
Dana G Mead Jr. مدير 8 أغسطس، 2016 A 202 0 0 $0
James K Outland مدير 13 يوليو، 2015 M 49986 0 0 $0
CHP III Management, L.L.C. مالك 10% 26 إبريل، 2017 J 2480468 0 0 $0
CHP III LP مالك 10% 26 إبريل، 2017 J 2480468 0 0 $0
Sandra L Fenwick · 21 مايو، 2026 A 12070 0 0 $0
Yulun Wang · 25 يناير، 2021 S 219507 0 0 $0
Michael Goldstein · 11 يونيو، 2020 M 0 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 37 صناديق مؤشرات متداولة

20

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
IHF · iShares Trust 0,16% 347966 SH 11 سبتمبر، 2026 يومي
VTWV · VANGUARD SCOTTSDALE FUNDS 0,10% 159976 SH 19 أغسطس، 2026 يومي
DFSV · Dimensional ETF Trust 0,08% 1038485 NS 31 يوليو، 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 0,05% 1047849 SH 19 أغسطس، 2026 يومي
ESML · iShares Trust 0,05% 219811 SH 11 سبتمبر، 2026 يومي
BBSC · J.P. Morgan Exchange-Traded Fund Tr… 0,05% 47383 NS 31 يوليو، 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,04% 29737 SH 19 أغسطس، 2026 يومي
RSSL · Global X Funds 0,04% 87202 NS 31 يوليو، 2026 N-PORT
IWM · iShares Trust 0,04% 4676471 SH 11 سبتمبر، 2026 يومي
VBR · VANGUARD INDEX FUNDS 0,03% 2631374 SH 19 أغسطس، 2026 يومي
PNQI · Invesco Exchange-Traded Fund Trust 0,03% 27091 SH 1 أكتوبر، 2026 يومي
DFAT · Dimensional ETF Trust 0,02% 528876 NS 31 يوليو، 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0,02% 2084219 SH 19 أغسطس، 2026 يومي
VB · VANGUARD INDEX FUNDS 0,02% 4153113 SH 19 أغسطس، 2026 يومي
VHT · VANGUARD WORLD FUND 0,02% 535056 SH 19 أغسطس، 2026 يومي
FHLC · FIDELITY COVINGTON TRUST 0,02% 83458 NS 31 يوليو، 2026 N-PORT
DFAS · Dimensional ETF Trust 0,01% 325784 NS 31 يوليو، 2026 N-PORT
DXUV · Dimensional ETF Trust 0,01% 11242 NS 31 يوليو، 2026 N-PORT
PRF · Invesco Exchange-Traded Fund Trust 0,01% 176576 SH 1 أكتوبر، 2026 يومي
WSML · iShares Trust 0,01% 10496 SH 11 سبتمبر، 2026 يومي
TILT · FlexShares Trust 0,01% 21330 NS 31 يوليو، 2026 N-PORT
DFAC · Dimensional ETF Trust 0,01% 449072 NS 31 يوليو، 2026 N-PORT
DFSU · Dimensional ETF Trust 0,01% 18459 NS 31 يوليو، 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 23195 NS 31 يوليو، 2026 N-PORT
DSI · iShares Trust 0,00% 25114 SH 10 سبتمبر، 2026 يومي
DFUS · Dimensional ETF Trust 0,00% 82328 NS 31 يوليو، 2026 N-PORT
DFAU · Dimensional ETF Trust 0,00% 43186 NS 31 يوليو، 2026 N-PORT
ITOT · iShares Trust 0,00% 232868 SH 11 سبتمبر، 2026 يومي
IWV · iShares Trust 0,00% 45761 SH 3 سبتمبر، 2026 يومي
DFUV · Dimensional ETF Trust 0,00% 16298 NS 31 يوليو، 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0,00% 5687282 SH 19 أغسطس، 2026 يومي
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 15175 SH 19 أغسطس، 2026 يومي
IWN · iShares Trust · 1697159 SH 11 سبتمبر، 2026 يومي
SVAL · iShares Trust · 100159 SH 3 سبتمبر، 2026 يومي
ISCB · iShares Trust · 7717 SH 11 سبتمبر، 2026 يومي
ISCV · iShares Trust · 38629 SH 11 سبتمبر، 2026 يومي
SMLF · iShares Trust · 597716 SH 11 سبتمبر، 2026 يومي

TDOC توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

21
تصنيف · 31 محللين احتفاظ
السعر المستهدف الوسيط $7.50 +35,9%
4 12,9% شراء قوي
7 22,6% شراء
20 64,5% احتفاظ
0 0,0% بيع
0 0,0% بيع قوي

السعر المستهدف لمدة 12 شهرًا

17 محللين · 2026-10-02

السعر المستهدف المتوسط $7.68 +39,1%

الآن السعر الحالي $5.52
منخفض$5.50 المتوسط$7.68 مرتفع$10.50

مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع

22

أساس السنة المالية، الأسعار كما في إغلاق نهاية السنة المالية الأخيرة لكل شركة.

الرمز القيمة السوقية P/E الإيرادات سنويًا هامش الربح الصافي ROE هامش الربح الإجمالي
TDOC $1.25B -6.1 -1.5% -7.9% -14.3% ·
HTFL $2.49B -9.2 39.9% -66.3% 39.3% 76.8%
SDGR · -12.7 23.3% -40.4% -29.2% 55.7%
CERT $1.40B -881.0 8.8% -0.38% -0.15% ·
GDRX · 30.1 0.57% 3.8% 4.8% ·
HSTM $682M 37.8 4.3% 6.0% 5.2% ·
PHR · 335.8 14.5% 0.48% 0.73% ·
CTEV $708M -2.5 3.7% -29.4% 265.9% ·
VEEV $33.40B 37.5 16.3% 28.4% 13.1% 75.5%

آخر الأخبار أحدث العناوين التي تذكر هذه الشركة

23

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

26

اختر المقاييس التي تهمك — انقر فوق علامة + بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

المصدر: إيداع SEC 10-Q بتاريخ يوليو 30, 2026